Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1995-12-12
pubmed:abstractText
A fraction of activated CD8+ T cells expresses CD40 ligand (CD40L), a molecule that plays a key role in T cell-dependent B cell stimulation. CD8+ T cell clones were examined for CD40L expression and for their capacity to allow the growth and differentiation of B cells, upon activation with immobilized anti-CD3. According to CD40L expression, CD8+ clones could be grouped into three subsets. CD8+ T cell clones expressing high levels of CD40L (> or = 80% CD40L+ cells) were equivalent to CD4+ T cell clones with regard to induction of tonsil B cell proliferation and immunoglobulin (Ig) production, provided the combination of interleukin (IL)-2 and IL-10 was added to cultures. CD8+ T cell clones, with intermediate levels of CD40L expression (10 to 30% CD40L+ cells), also stimulated B cell proliferation and Ig secretion with IL-2 and IL-10. B cell responses induced by these CD8+ T cell clones were neutralized by blocking monoclonal antibodies specific for either CD40L or CD40. By contrast, CD40L- T cell clones (< or = 5% CD40L+ cells), only induced marginal B cell responses even with IL-2 and IL-10. All three clone types were able to activate B cells as shown by up-regulation of CD25, CD80 and CD86 expression. A neutralizing anti-CD40L antibody indicated that T cell-dependent B cell activation was only partly dependent on CD40-CD40L interaction. These CD40L- clones had no inhibitory effects on B cell proliferation induced by CD40L-expressing CD8+ T cell clones. Taken together, these results indicate that CD8+ T cells can induce B cell growth and differentiation in a CD40L-CD40-dependent fashion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0014-2980
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2972-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:7589100-Animals, pubmed-meshheading:7589100-Antibody Formation, pubmed-meshheading:7589100-Antigens, CD80, pubmed-meshheading:7589100-B-Lymphocytes, pubmed-meshheading:7589100-CD40 Ligand, pubmed-meshheading:7589100-CD8-Positive T-Lymphocytes, pubmed-meshheading:7589100-Cell Differentiation, pubmed-meshheading:7589100-Cell Division, pubmed-meshheading:7589100-Cells, Cultured, pubmed-meshheading:7589100-Clone Cells, pubmed-meshheading:7589100-Dipeptidyl Peptidase 4, pubmed-meshheading:7589100-Flow Cytometry, pubmed-meshheading:7589100-Humans, pubmed-meshheading:7589100-Interleukin-10, pubmed-meshheading:7589100-Interleukin-2, pubmed-meshheading:7589100-L Cells (Cell Line), pubmed-meshheading:7589100-Lymphocyte Activation, pubmed-meshheading:7589100-Lymphocyte Cooperation, pubmed-meshheading:7589100-Membrane Glycoproteins, pubmed-meshheading:7589100-Mice, pubmed-meshheading:7589100-Mitogens, pubmed-meshheading:7589100-Palatine Tonsil, pubmed-meshheading:7589100-Phytohemagglutinins, pubmed-meshheading:7589100-Receptors, Interleukin-2, pubmed-meshheading:7589100-T-Lymphocyte Subsets, pubmed-meshheading:7589100-Transfection, pubmed-meshheading:7589100-Up-Regulation
pubmed:year
1995
pubmed:articleTitle
CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
pubmed:affiliation
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't